Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria
- 300 Downloads
To describe the clinical features, risk factors for severe disease and effectiveness of oseltamivir in patients with 2009 pandemic influenza A (H1N1) virus infection.
In a prospective, cross-sectional, multicentre study, data on 540 patients with confirmed 2009 H1N1 infection from seven Austrian hospitals were collected using a standardised online case-history form.
The median age of the patients was 19.3 years (range 26 days–90.8 years); point-of-care testing yielded false-negative results in 60.2% of the 176 cases tested. The most common symptoms were fever, cough, fatigue and headache. Overall, 343 patients (63.5%) were hospitalised, 49 (9.1%) were admitted to an intensive care unit (ICU) and 14 (4.1%) died. Case fatality rates were highest (9.1%) in those aged 65 years or older. Factors significantly associated with a higher risk for ICU admission included age, neurological disease, adipositas, and both interstitial pathology and lobular pathology on chest X-ray. No association with pregnancy, malignancy or immunosuppressive therapy was detected. Antiviral treatment significantly reduced the duration of fever by 0.66 days and lowered the risk of ICU admission, but had no significant benefit on survival.
During the 2009 H1N1 influenza pandemic, elderly or obese patients and those with neurological disease had an increased risk for severe H1N1 infection in Austria. Pregnancy was not associated with a higher risk for severe disease in the later phase of the 2009 H1N1 pandemic. Antiviral treatment provided a minimal effect on the symptoms of influenza but reduced the risk of admission to an ICU.
KeywordsInfluenza Pandemic H1N1 Risk factor
Conflict of interest
The authors declare that they have no conflicts of interest.
- 3.Gilsdorf A, Poggensee G. Influenza A(H1N1)v in Germany: the first 10,000 cases. Euro Surveill. 2009;14. pii=19318.Google Scholar
- 4.Kelly H, Grant K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill. 2009;14. pii=19288.Google Scholar
- 6.Nishiura H, Castillo-Chavez C, Safan M, Chowell G. Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. Euro Surveill. 2009;14(22). pii=19227.Google Scholar
- 7.Centers for Disease Control and Prevention (CDC). Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection—United States, April–August 2009. MMWR Morb Mortal Wkly Rep. 2009;58:941–7.Google Scholar
- 8.Chen M. World now at the start of 2009 influenza pandemic. World Health Organization (WHO). 2009. http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html.
- 10.Austrian Federal Ministry of Health. Ein Jahr Neue Grippe—Die Maßnahmen des Gesundheitsministeriums. 2010. http://www.bmg.gv.at/home/Presse/Pressemeldungen/Ein_Jahr_Neue_Grippe_Die_Massnahmen_des_Gesundheitsministeriums.
- 11.Redlberger-Fritz M, Popow-Kraupp T. Rückblick auf die erste Welle der Influenza A/H1N1v-Pandemie 2009/2010. Virusepidemiologische Information 05/10. 2010. http://www.virologie.meduniwien.ac.at/home/upload/vei/2010/0510s.pdf.
- 12.Depoortere E, Mantero J, Lenglet A, Kreidl P, Coulombier D. Influenza A(H1N1)v in the southern hemisphere—lessons to learn for Europe? Euro Surveill. 2009;14. pii=19246.Google Scholar
- 13.Austrian Agency for Health and Food Safety (AGES). Zur Situation in Österreich. 2010. http://www.ages.at/ages/gesundheit/mensch/neue-grippe-ah1n1.
- 18.Santa-Olalla Peralta P, Cortes-García M, Vicente-Herrero M, Castrillo-Villamandos C, Arias-Bohigas P, Pachon-del Amo I, et al. Risk factors for disease severity among hospitalised patients with 2009 pandemic influenza A (H1N1) in Spain, April–December 2009. Euro Surveill. 2010;15. pii=19667.Google Scholar
- 26.Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill. 2009;14. pii=19309.Google Scholar
- 33.[No authors listed]. Transmission dynamics and impact of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec. 2009;84:481–4.Google Scholar
- 40.Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)—United States, May–August 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1071–4.Google Scholar
- 42.Centers for Disease Control and Prevention (CDC). Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus—United States, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:826–9.Google Scholar
- 44.Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, et al. Seasonal influenza in adults and children—diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1003–32.PubMedCrossRefGoogle Scholar